VUMC Calendar of Events. @import url(/calendar/ui.datepicker.css); Referring a patient to Vanderbilt Patients & Visitors click here Entire Site Today Add an Event Vanderbilt Ingram Cancer Center Events No calendar items found. Find Us On: Vanderbilt University Medical Center 1211 Medical Center Drive Nashville, TN 37232 Vanderbilt University is committed to principles of equal opportunity and affirmative action. My Health Chat: Your Genome and the Future of Medicine. Bridgestone Arena's 15th Anniversary Celebration - Nashville Predators - Features. Every week throughout Bridgestone Arena's Anniversary Season, we will celebrate the Arena's 15 year partnership with the Middle Tennessee community.
The Nashville Predators players and team/arena staff are strong partners with Vanderbilt University in the fight for cancer research, ranging from monetary support (over the last three years alone, the Nashville Predators Foundation has donated around a half million dollars to Monroe Carell Jr. Children's Hospital at Vanderbilt) to increased awareness and exposure to volunteerism and staff assistance. Preds players are frequent visitors to Children's Hospital in-season and out-of-season, while patients and their families are regular guests of the team at Preds games and other Arena events. Meg Rush, M.D., Monroe Carell Jr Children's Hospital at VanderbiltDr. Meg Rush is chief of staff at Children's Hospital and is also the acting chair of the Department of Pediatrics. Fact Of The Week: The Center for Science in the Public Interest Says That Soda Coloring Can Cause Cancer. Is It True?
Soda is not good for you. The high-calorie, sugary drinks have been linked to obesity and a host of other health problems. Soda can be particularly dangerous to children, who can consume lots of calories quickly through colas and other pop without feeling full. And then there’s the dental toll — it doesn’t take a peer-reviewed study to tell you that drinking lots of sweetened soda isn’t great for your teeth.
But soda isn’t just water, corn syrup and carbonation — a can of Coke or Pepsi also contains chemical additives for coloring and flavoring. That’s the message from the Center for Science in the Public Interest (CSPI), a Washington-based consumer watchdog group. CSPI says the artificial brown coloring — which doesn’t have much to do with actual caramel, despite the name — is made by reacting corn sugar with ammonia and sulfites under high pressures and at high temperatures. Is Jacobson right?
The soda industry, however, is fighting back. 4-MEI is not a threat to human health. Coke and Pepsi hear it from the food police. By Jonathan BerrCoca-Cola (KO -0.67%), PepsiCo (PEP -0.56%) and the rest of the carbonated beverage industry have become public enemy No. 1 for the nation's self-appointed food police, and the battle is far from over. The Center for Science in the Public Interest (CSPI) on Monday announced that it had found "high levels of 4-methylimidazole (4-MI), a known animal carcinogen" in samples of Coca-Cola, Pepsi, Diet Coke and Diet Pepsi that the group analyzed.
The chemical is a byproduct of the manufacturing process used to create the distinctive brown caramel color in these popular beverages. Wall Street shrugged off the news, with shares of Coca-Cola and PepsiCo not showing much reaction during Monday trading. KO barely budged, and PEP was up 0.4% on the day. Still, investors should take the CSPI test seriously because it can be a formidable foe to the food industry. Among CSPI's other fights are one with McDonald's (MCD -0.14%) over the marketing of Happy Meal toys to kids. Town Hall on the Multidisciplinary Management of NSCLC: A Community Perspective. Robotic surgeries costlier but safer, study finds.
Patients who have robot-assisted surgeries on their kidneys or prostate have shorter hospital stays and a lower risk of having a blood transfusion or dying -- but the bill is significantly higher, a study found. The analysis, which appeared in the Journal of Urology, compared increasingly common robotic surgery with two other techniques for the same surgery and found that direct costs can be up to several thousand dollars higher for the robotic type. Touted as less invasive and more efficient, robotic surgeries typically use a laparoscopic or "keyhold surgery" approach, in which tools and a tiny video camera are inserted into the body through one or two small incisions.
Robotic surgery replaces a surgeon's hands with ultra-precise tools at the ends of mechanical arms, all operated by the surgeon from a console. Hu and his team analyzed surgery data from a national government database to see if the costlier robotic surgeries were cost effective with extra benefits over older techniques. Dress in Blue Day. National Friday, March 1st, 2013 Raise awareness about colon cancer, celebrate survivors, and help patients in need during National Colorectal Cancer Awareness Month by participating in the program.
We urge you to get out and get people talking about this disease. Colon cancer is often beatable when caught early, yet it is still the second leading cause of cancer deaths in the United States. Join the more than one million survivors, patients, caregivers, and others who have been affected by colon cancer by wearing blue and getting involved in the fight against this terrible disease. Together, we can work toward a future free of colon cancer. Dress in Blue Day is sponsored by *For the time being, the Colon Cancer Alliance (CCA) does not claim trademark rights to in the state of Washington, and the CCA is not providing goods or services affiliated with in the state of Washington. Lung cancer screening trial helps first patient (03/1. Mostly Cloudy Nashville, TN Lung cancer study participant Kathy Leiser talks with Pierre Massion, M.D., left, and Eric Grogan, M.D., MPH, during a recent follow-up visit.
(photo by Joe Howell) 3/01/2012 - Kathy Leiser first heard about Vanderbilt-Ingram Cancer Center’s lung cancer screening trial through a sponsorship ad on WPLN radio last summer. The Nashville office technology saleswoman and grandmother of three had stopped smoking in 2009, but she knew her smoking history put her at risk for lung cancer.
So she enrolled in the screening trial, a decision that may have prolonged her life. “I had no symptoms, I wasn’t sick, but my risk factor would have been high because I smoked on and off most of my life,” said Leiser. The accumulated years of smoking made Leiser a perfect candidate for the Nashville Lung Cancer Screening Trial, a research project led by principal investigator Pierre Massion, M.D., associate professor of Medicine and Cancer Biology. Surgical teamwork boosts cancer patients odds (02/23. Fair Nashville, TN Ronald Denton is recovering from surgery to repair damage to his spine caused by a tumor. (photo by Anne Rayner) 2/23/2012 - The first surgery Eric Grogan, M.D., and Matthew McGirt, M.D., performed together lasted 18 hours.
Grogan, a thoracic surgeon, carefully cut away the baseball-sized lung tumor that had wrapped around patient Ronald Denton’s aorta, subclavian artery and esophagus and removed the upper lobe of the lung. After they worked together to remove three vertebrae that the tumor had invaded, McGirt, a neurosurgeon, rebuilt and reinforced the vertebrae that had been destroyed by the encroaching tumor.
Eric Grogan, M.D. Matthew McGirt, M.D. For Denton, their teamwork equaled a greater chance at survival. “Most surgeons and oncologists would deem this tumor unresectable, but with the right multidisciplinary team a surgical cure may be achieved,” Grogan said. “Without our multidisciplinary team, the surgical cure is not an option and Mr. Studies pinpoint new anti-cancer drug target (02/23. Fair Nashville, TN Alison Hanson, Ph.D., and Ethan Lee, M.D., Ph.D., are studying a new molecular participant in a signaling pathway important in cell growth, development and cancer.
(photo by Anne Rayner) 2/23/2012 - A few years ago, Alison Hanson, Ph.D., a student in Vanderbilt’s Medical Scientist Training Program, was invited to have lunch with a visiting Nobel laureate, Aaron Ciechanover, M.D., D.Sc. Hanson was working on her dissertation research at the time, and she described some interesting findings to Ciechanover.
“He said, ‘that could either be a total artifact or it could be the discovery of the century,’” Hanson recalled. It wasn’t a total artifact. Hanson, her mentor Ethan Lee, M.D., Ph.D., and colleagues have discovered a new molecular participant in the Wnt (pronounced “wint”) signaling pathway, which plays important roles in cell growth, development and cancer. More than a year later, Hanson decided to follow up on the shelved findings. University Medical Center - New melanoma drug nearly doubles survival in majority of patients. Vanderbilt-Ingram Cancer Center researchers helped lead trial Investigators from Vanderbilt-Ingram Cancer Center (VICC) and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival.
More than half of patients who were treated with the novel drug vemurafenib, known commercially as Zelboraf, responded to treatment and experienced an impressive median overall survival of nearly 16 months – far longer than the typical survival of just six to 10 months for most patients whose melanoma has spread beyond the initial tumor site. Results from the Phase 2 trial, led by co-principal investigators Jeffrey Sosman, M.D., director of the Melanoma Program and co-leader of the Signal Transduction Program at VICC, and Antoni Ribas, M.D., professor of Hematology/Oncology at UCLA’s Jonsson Comprehensive Cancer Center, were published in the Feb. 23 issue of the peer-reviewed New England Journal of Medicine. Aliquots research highlights from VUMC laboratories (02/16. Cloudy Nashville, TN Aliquots — research highlights from VUMC laboratories ‘Acid test’ for cervical cancer Women infected with human immunodeficiency virus (HIV) constitute one of the populations at highest risk for human papillomavirus-induced cervical cancer.
While HIV-infected women in developing countries, such as India, are living longer thanks to antiretroviral therapy, their risk of invasive cervical cancer remains high due to lack of access to affordable and accurate cervical cancer screening and prevention services. Visual inspection of the cervix after application of dilute acetic acid (household vinegar), or VIA, is being studied as a low-tech, low-cost alternative to the traditional screening method for cervical cancer: the Pap smear (or cervical cytology).
The research was supported by grants from the National Cancer Institute, the National Institutes of Health’s Fogarty International Center and the Indian Council of Medical Research. — Melissa Marino Stem cells take heart. Vanderbilt-Ingram Cancer Center - VICC Green Hills Community Seminars. Health topics Doctors Locations A-Z directory For Patients and Visitors Vanderbilt Health Still Smoking? The Vanderbilt-Ingram Cancer Center invites you to a free educational seminar on smoking cessation tips and your options for lung cancer screening. First Name: Last Name: Phone Number: Email: Number of People Attending: How did you hear about the seminar? Featured Speakers Barbara Forbes, M.S., APN, GNP Director of the Dayani Institute for Smoking Cessation and Prevention Barbara Forbes offers tobacco cessation counseling, evaluates potential members of Dayani’s Senior Wellness Program, and coordinates volunteers.
Pierre Massion, M.D. Dr. To learn more about our sessions, visit www.VanderbiltCancerSeminars.com Find Us On: Health Topics Doctors Locations Guide to VUMC My Health at Vanderbilt For Referring Physicians Giving Volunteer Media Quality Answers Careers Pay Your Bill About VUMC Feedback Privacy Policy Vanderbilt University Medical Center 1211 Medical Center Drive Nashville, TN 37232. Juvenile Idiopathic Arthritis Linked to Elevated Cancer Risk in New Study. <br/><a href=" US News</a> | <a href=" Business News</a> Copy Children with juvenile idiopathic arthritis (JIA), the most common form of childhood arthritis, may be at higher risk of developing cancer than children who do not have the condition, according to a new study published in the journal Arthritis & Rheumatism. Researchers identified 7,812 children with JIA and compared them with thousands of children not affected by JIA and found that the arthritic children developed about four times as many new growths considered likely to be cancerous as children who did not have arthritis.
They followed the children for about 18 months. "Based on the data, it appears that being diagnosed with JIA increases the likelihood of developing malignancies," said Dr. But despite the statistically higher risk, Dr. "The risk is very low, and it's more common for children with JIA to not get cancer," he said. What Do Cancer and Sin Have in Common? February 3, 2012 Watch video of Dr. Michael Neuss speaking about cancer. Neuss spoke Feb. 1 as part of the Osher Lifelong Learning class, “Medical Advances.” The course is presented by faculty of the Vanderbilt University Medical Center and focuses on what the future of medicine holds. Physicians are now able to use a patient’s DNA to select the right drug for treatment. The class is part of the Osher Lifelong Learning Institute at Vanderbilt. No comments yet. Sorry, the comment form is closed at this time.
Eating more fish may lower womens colon polyp risk (02/9. Fair Nashville, TN Women who eat three servings of fish per week have a lower risk of developing some types of colon polyps, according to a Vanderbilt-Ingram Cancer Center study. (iStock image) 2/09/2012 - Women who eat at least three servings of fish per week have a reduced risk of developing some types of colon polyps, according to a new study by Vanderbilt-Ingram Cancer Center investigators. The research, led by first author Harvey Murff, M.D., MPH, associate professor of Medicine, was published recently in the American Journal of Clinical Nutrition. Harvey Murff, M.D., MPH The VICC researchers said that omega-3 fats in fish may reduce inflammation in the body and help protect against the development of colon polyps. Earlier research in animals has suggested a link between inflammation and colon polyp formation, but studies in humans have not been conclusive.
Colorectal cancer is the fourth most common cancer and the second leading cause of cancer-related death in the United States. Help put childhood cancer on ice at Predators game March 10. New Lung Cancer Therapy -- In Depth Doctor's Interview. Racing stars grant to help children stay connected during treatment (02/2. Vanderbilt-Ingram Cancer Center - Home. University Medical Center - Vanderbilt study finds prostate size may help predict cancer severity. Wellness Wednesday: Cancer Supportive Care.
Pink Out! game to tip off Jan. 29 (01/26. Colorectal cancer risk related to genes expression (01/26. Aliquots research highlights from VUMC laboratories (01/19. Photo: Blackhawk visits VICC (01/19. My Cancer Genome wins technology award (01/12. Mutations Offer Clues to Lung Cancer in Nonsmokers - in Meeting Coverage, AACR-IASLC from MedPage Today. VU study applies random genotype sets to new disease (01/6. Gains in cancer fight, but not for young adults. What Types of Cancer Are On the Rise? - Health Blog. Wellness Wednesday: Nutrition Before and After Cancer. Wellness Wednesday: Nutrition Before and After Cancer.
Vitamin C may help prevent stomach cancer. If It's Not a War on Cancer, What Is It? | PBS NewsHour | Dec. 22, 2011. VICC named to proteomic cancer research consortium (12/8. Cohens Nobel-winning work stands test of time (12/8. Cancer’s Escape Routes. For Patients - My Health Chat. Nashville hospitals to hold trials for promising cancer vaccines. Marnetts research lauded by American Chemical Society (11/3. MyCancerGenome finalist for technology award (10/27. Protein family key to aging linked to suppressing tumors (10/27. Panel Recommends HPV Vaccine for Boys and Young Men. Family Day to benefit T.J. Martell Foundation (10/20. Nolan weathers cancers storms (10/20. Robotic surgery now offered for colorectal cases (10/6. Join Us for Wellness Wednesday. VICC seeks to halt colorectal cancers impact on family (09/29.
Cancer Queens sing silly songs to save lives. VICC solidifies research administration leadership (09/1. Lane Adams Award. Triple-negative breast cancer study may help guide treatment plan (06/30. National Lung Screening Trial: What's Next? Different subtypes of triple-negative breast cancer respond to different therapies. My Cancer Genome - Vanderbilt-Ingram Cancer Center. Songwriter Nielsen Chapman shares cancer survival story. FDA reveals bigger, graphic warning labels for cigarette packages. 40 Years of Cancer Research: What Will The Next 40 Bring? Sunscreen. 40 Years of Cancer Research: What Will The Next 40 Bring? Weaver honored by neurological surgery association (06/9. Vanderbilt Celebrates Cancer Survivors
VUMCcancer. Celebrate Survivors’ Day on June 18. Opens new clinic for lymphedema therapy (05/26. Huge new magnet to enhance cancer drug discovery efforts (05/12. Westhaven: Race 4 the Cure funds help Vanderbilt doctor's research. Be Smart About the Sun. VICC investigators shine at national conference (04/14. Cancer Registrars Week - National Cancer Registrars Association.
Mobile. Soy back on menu for breast cancer survivors (04/7. New Target Drug For Lung Cancer? Cancer genes role in outcomes prediction studied (03/24. Take a Video Tour of the “Super Colon”